Northrop Grumman Valuation
Is NOC * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
1/6Valuation Score 1/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of NOC * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: NOC * (MX$7808.85) is trading above our estimate of fair value (MX$7358.7)
Significantly Below Fair Value: NOC * is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for NOC *?
Other financial metrics that can be useful for relative valuation.
What is NOC *'s n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | US$62.66b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 1.9x |
Enterprise Value/EBITDA | 18.7x |
PEG Ratio | 2.1x |
Price to Earnings Ratio vs Peers
How does NOC *'s PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 26.4x | ||
GD General Dynamics | 23.6x | 9.2% | US$80.1b |
GCARSO A1 Grupo Carso. de | 24x | 27.0% | Mex$307.4b |
BA. BAE Systems | 22.4x | 6.7% | UK£41.6b |
LHX L3Harris Technologies | 35.4x | 17.4% | US$41.6b |
NOC * Northrop Grumman | 29.1x | 14.0% | Mex$62.7b |
Price-To-Earnings vs Peers: NOC * is expensive based on its Price-To-Earnings Ratio (29.1x) compared to the peer average (26.2x).
Price to Earnings Ratio vs Industry
How does NOC *'s PE Ratio compare vs other companies in the Global Aerospace & Defense Industry?
Price-To-Earnings vs Industry: NOC * is good value based on its Price-To-Earnings Ratio (29.1x) compared to the Global Aerospace & Defense industry average (37.1x).
Price to Earnings Ratio vs Fair Ratio
What is NOC *'s PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 29.1x |
Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate NOC *'s Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | Mex$7,808.85 | Mex$8,946.04 +14.6% | 10.3% | Mex$10,461.03 | Mex$7,081.31 | n/a | 21 |
Jun ’25 | n/a | Mex$8,533.63 0% | 10.3% | Mex$9,924.93 | Mex$6,718.42 | n/a | 21 |
May ’25 | Mex$8,265.00 | Mex$8,511.59 +3.0% | 10.3% | Mex$9,956.70 | Mex$6,739.92 | n/a | 22 |
Apr ’25 | n/a | Mex$8,270.31 0% | 11.4% | Mex$10,466.44 | Mex$6,552.16 | n/a | 22 |
Mar ’25 | n/a | Mex$8,305.27 0% | 11.6% | Mex$10,495.96 | Mex$6,570.64 | n/a | 22 |
Feb ’25 | Mex$7,452.51 | Mex$8,409.28 +12.8% | 11.6% | Mex$10,591.84 | Mex$6,630.66 | n/a | 22 |
Jan ’25 | n/a | Mex$8,543.37 0% | 11.1% | Mex$10,558.26 | Mex$6,558.14 | n/a | 22 |
Dec ’24 | n/a | Mex$8,797.91 0% | 11.1% | Mex$10,760.96 | Mex$6,684.05 | n/a | 21 |
Nov ’24 | Mex$8,572.81 | Mex$9,063.84 +5.7% | 11.1% | Mex$11,088.33 | Mex$6,887.38 | n/a | 21 |
Oct ’24 | n/a | Mex$8,747.14 0% | 11.5% | Mex$10,875.35 | Mex$6,790.46 | n/a | 20 |
Sep ’24 | n/a | Mex$8,344.55 0% | 11.4% | Mex$10,327.94 | Mex$6,448.67 | n/a | 19 |
Aug ’24 | Mex$7,576.79 | Mex$8,361.62 +10.4% | 11.3% | Mex$10,297.81 | Mex$6,429.85 | n/a | 19 |
Jul ’24 | n/a | Mex$8,585.72 0% | 13.3% | Mex$11,208.36 | Mex$6,571.01 | n/a | 19 |
Jun ’24 | n/a | Mex$8,886.09 0% | 13.4% | Mex$11,585.90 | Mex$6,792.35 | n/a | 19 |
May ’24 | Mex$8,184.85 | Mex$9,204.76 +12.5% | 13.0% | Mex$11,776.83 | Mex$6,904.28 | Mex$8,265.00 | 19 |
Apr ’24 | n/a | Mex$9,421.26 0% | 13.4% | Mex$12,082.39 | Mex$6,769.83 | n/a | 19 |
Mar ’24 | Mex$8,754.24 | Mex$9,774.87 +11.7% | 13.8% | Mex$12,545.80 | Mex$7,029.48 | n/a | 18 |
Feb ’24 | Mex$8,230.00 | Mex$9,617.75 +16.9% | 14.0% | Mex$12,196.76 | Mex$6,833.91 | Mex$7,452.51 | 18 |
Jan ’24 | n/a | Mex$11,062.66 0% | 12.5% | Mex$13,829.62 | Mex$7,270.43 | n/a | 19 |
Dec ’23 | Mex$10,120.00 | Mex$10,683.24 +5.6% | 12.8% | Mex$13,532.61 | Mex$7,114.29 | n/a | 18 |
Nov ’23 | Mex$10,580.33 | Mex$10,599.45 +0.2% | 13.1% | Mex$13,803.93 | Mex$7,256.92 | Mex$8,572.81 | 18 |
Oct ’23 | Mex$9,463.00 | Mex$10,136.96 +7.1% | 9.8% | Mex$11,268.88 | Mex$7,405.26 | n/a | 16 |
Sep ’23 | Mex$9,650.00 | Mex$10,071.04 +4.4% | 10.1% | Mex$11,280.98 | Mex$7,413.21 | n/a | 16 |
Aug ’23 | Mex$9,384.00 | Mex$10,079.26 +7.4% | 9.8% | Mex$11,211.26 | Mex$7,501.35 | Mex$7,576.79 | 15 |
Jul ’23 | n/a | Mex$9,592.14 0% | 11.4% | Mex$10,917.89 | Mex$7,205.80 | n/a | 14 |
Jun ’23 | Mex$9,300.00 | Mex$9,427.94 +1.4% | 11.2% | Mex$10,780.39 | Mex$7,115.05 | n/a | 15 |
Analyst Forecast: Target price is less than 20% higher than the current share price.